Cantor Fitzgerald Adjusts Eli Lilly Price Target to $1,350 From $1,230
Eli Lilly and Company (LLY) has an average rating of overweight and mean price target of $1,269.54, according to analysts polled by FactSet. ( covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: )
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.